AstraZeneca is set to prioritize the treatment of early-stage cancers under the leadership of oncology research chief José Baselga, M.D., Ph.D. Talking to The Wall Street Journal, Baselga sketched out why he thinks splitting off from the congested pursuit of late-stage cancers will benefit AstraZeneca and patients. Under Baselga, AstraZeneca’s oncology group will initially test drugs in
With gene therapies becoming a hot growth area, CDMOs are figuring out how to get a bigger piece of the market. Thermo Fisher Scientific decided to buy its way in, agreeing to pay $1.7 billion to get viral vector producer Brammer Bio. The cash deal, slated to close by the end of the second quarter, will see Waltham,
Boehringer Ingelheim has been working to boost its research capabilities in central nervous system (CNS) disorders, making moves over the past year aimed specifically at adding compounds to its pipeline to address Alzheimer’s disease (AD), schizophrenia and depression. Now it’s teaming up with Vanderbilt University, located in Nashville to develop novel small molecules that modulate
Recently, Swiss biotech company Lonza officially opened its new cell and gene therapy manufacturing plant in Pearland, near Houston, Texas. The facility’s 300,000 square feet make it the world’s largest manufacturing plant devoted to making these types of materials, according to a statement. “This facility has the potential to produce treatment for thousands of patients
As part of the formal launch of our US office in Cambridge, MA, CPL Physicians, a sister brand to UK based Only Medics and part of the Clinical Professionals Group, hosted an event that brought together a number of eminent senior physicians from the greater Boston Biopharma and Med Tech industry. In an intimate dining
With CAR-T therapies reaching the market, Japanese drugmaker Takeda has made a bid to get in on the action with a deal with biotech startup Noile-Immune. The agreement gives Takeda a line into the work of Professor Koji Tamada at Yamaguchi University in Japan, who is a founder and chief scientific and medical officer at
